In recent years, there has been growing expectation that regenerative medicine, which uses a patient’s own cells, will be a new treatment method with the potential to cure diseases that have been difficult to cure until now.

In regenerative medicine, cells are cultured and multiplied, and then administered to patients in the desired condition and amount. In other words, cells are the raw material and also contain cells in the final product, and cells are manufactured at each phase of regenerative medicine research and development, clinical trials, and commercial production.

However, at present, the cost of cell production is high, and the price at which cells are provided to patients also remains high, so regenerative medicine has not yet become widespread. Although many promising regenerative medicine seeds have been developed, only a limited number have been put to practical use.